Travere Therapeutics
TVTX
TVTX
122 hedge funds and large institutions have $874M invested in Travere Therapeutics in 2019 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 54 increasing their positions, 37 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
122
Holders Change
-8
Holders Change %
-6.15%
% of All Funds
2.65%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
18
Increased
54
Reduced
37
Closed
24
Calls
$8.57M
Puts
$48M
Net Calls
-$39.4M
Net Calls Change
-$25.5M
Top Buyers
| 1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$20.2M |
| 2 |
PA
Perceptive Advisors
New York
|
+$14.4M |
| 3 |
Nuveen Asset Management
Chicago,
Illinois
|
+$14.3M |
| 4 |
Millennium Management
New York
|
+$6.71M |
| 5 |
BlackRock
New York
|
+$6.66M |
Top Sellers
| 1 |
Jennison Associates
New York
|
-$13.4M |
| 2 |
GTC
Ghost Tree Capital
New York
|
-$11.3M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$7.34M |
| 4 |
SCM
Scopia Capital Management
New York
|
-$6.64M |
| 5 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$5.87M |
